Canario, Norma T.
HRN: 06-06-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/11/2022
10/17/2022
IV
4.5gm Now Then 2.25
Q12
Infected Wound Right Foot
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes